For US Residents Only

About AMD
AMD Warning Signs
Treating AMD
- Treating Wet AMD
Visudyne
Support for Low Vision
Caregiving
Common Questions
Helpful Resources

Age-related macular degeneration (AMD) is a progressive disease of the eye, meaning that it can’t be cured. The good news is that AMD can be controlled. Treatments available today can slow the vision loss associated with AMD and even restore some vision.

Wet and dry age-related macular degeneration (AMD) differ in several important respects, including treatment options. The only way to find out which AMD treatment regimen or management plan is right for you is to talk to your ophthalmologist or retinal specialist. If you don’t already have one, find a specialist here.

Treating Wet AMD

If you have been diagnosed with wet AMD, you should find out whether photodynamic therapy with Visudyne is right for you.

Visudyne therapy treats a form of AMD called predominantly classic subfoveal CNV due to AMD.

In this form of AMD, abnormal blood vessels leak fluid and/or blood under the macula—the part of the eye responsible for central vision—causing serious vision loss. During therapy, Visudyne is injected into the patient (generally through the arm). Next, light from a low-energy laser activates Visudyne, causing it to destroy the leaky vessels. As a part of a wet AMD treatment regimen, Visudyne therapy may help slow its progression. Ask your ophthalmologist or retinal specialist if Visudyne therapy may be right for you.

Other treatment options

Anti-VEGF (anti-vascular endothelial growth factor) treatments block the formation of new abnormal blood vessels

Ask about Visudyne therapy

If you've been diagnosed with AMD and are not receiving Visudyne therapy, ask your ophthalmologist or retinal specialist if Visudyne may be a good option for you. If you don’t have one, find a specialist here.

Is Visudyne for me?

Visudyne is a treatment to help slow the loss of vision in persons with predominantly classic wet AMD.

Important Safety Information

Visudyne therapy is not for everyone. People who have an abnormal sensitivity to light (a condition called porphyria) and those with allergies to any of the ingredients should not receive Visudyne. (Your doctor has a list of ingredients in Visudyne.) Check with your doctor or healthcare professional to see if you might be allergic to any component of Visudyne therapy. Only your doctor can determine if Visudyne is right for you.

Between 1% and 5% of patients experienced a substantial decrease in vision in the first 7 days after treatment, though some patients achieved partial recovery. Patients who experience substantial vision loss should consult their ophthalmologist or retinal specialist immediately. The most commonly reported adverse events (10-30%) were injection site reactions, temporary back pain during injection, changes in vision, including blurring, decreased sharpness in vision, and gaps in vision.

Patients should avoid direct sunlight or bright indoor light for 5 days following therapy with Visudyne.

Patients who have to go outdoors in daylight after treatment must protect all parts of their skin and eyes by wearing protective clothing and dark glasses. Ultraviolet (UV) sunscreens are not effective in protecting against photosensitivity reactions.